Retrospective study analyzes pediatric brain tumor outcomes with a visiting neuro-oncologist, suggesting effective collaboration in low-resource settings.
Objective To analyze the impact of a visiting consultant pediatric neuro-oncologist on the outcome of pediatric patients with brain tumors in a health care system with no consultant pediatric neuro-oncologist. Methodology This retrospective study was conducted at the Punjab Institute of Neurosciences, Lahore, Pakistan, involving pediatric patients with brain tumors from January 2023 to January 2025. Patients were assessed by a visiting pediatric neuro-oncologist. These patients were followed for one year, and outcomes were observed. Results This study included 45 patients who were assessed by a visiting neuro-oncologist; 82.22% (37) underwent craniotomy and excision, and 8.89% (4) had a biopsy. In histopathology, the most common tumor was glioma, with 37.78% (17) of patients, and 24.44% (11) were referred for adjuvant therapy by the visiting neuro-oncologist. After a one-year follow-up, 13 patients were lost to follow-up (LTFU) during their treatment, with an overall LTFU rate of 28.89%. Of those with complete follow-up, 90.63% of patients were healthy without any new neurological deficits. Conclusion In countries with limited resources and few specialists, particularly pediatric neuro-oncologists, such a collaboration of shared care can impact the management and outcome of the patients without pouring more resources. However, LTFU remains a major challenge to assess complete disease courses and management outcomes in clinical practice.
No takes yet. Share an insight, caveat, or question.
Qadri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: